Skip to main content
Have a personal or library account? Click to login
Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors Cover

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors

Radiology and Oncology
Volume 49 (2015): Issue 4 (December 2015)
By: ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|Nov 2015
Authors

Authors

Maja Lampelj

Darja Arko

Nina Cas-Sikosek

Rajko Kavalar

Maja Ravnik

Barbara Jezersek-Novakovic

Sarah Dobnik

sarah_dobnik@yahoo.com

Nina Fokter Dovnik

Iztok Takac

DOI: https://doi.org/10.2478/raon-2014-0049 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 357 - 364
Submitted on: Aug 3, 2014
Accepted on: Nov 11, 2014
Published on: Nov 27, 2015
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
urokinase plasminogen activator,
plasminogen activator inhibitor,
breast cancer,
prognostic factor
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2015 Maja Lampelj, Darja Arko, Nina Cas-Sikosek, Rajko Kavalar, Maja Ravnik, Barbara Jezersek-Novakovic, Sarah Dobnik, Nina Fokter Dovnik, Iztok Takac, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 49 (2015): Issue 4 (December 2015)
Previous article
Next article